Australian university students' attitudes towards the acceptability and regulation of pharmaceuticals to improve academic performance

Neuroethics

Volumn 6, Issue 1, 2013, Pages 197-205

  Bell, Stephanie ^a   Partridge, Brad ^a   Lucke, Jayne ^a   Hall, Wayne ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Attitudes; Cognitive enhancement; Neuroenhancement; Qualitative research; Stimulants

Indexed keywords

METHYLPHENIDATE; PSYCHOSTIMULANT AGENT; STEROID;

ACADEMIC ACHIEVEMENT; ADULT; ARTICLE; AUSTRALIA; BIOETHICS; COGNITION; DRUG CONTROL; DRUG USE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; QUALITATIVE RESEARCH; SEMI STRUCTURED INTERVIEW; SPORT; STUDENT ATTITUDE; UNIVERSITY STUDENT;

EID: 84875244396     PISSN: 18745490     EISSN: 18745504     Source Type: Journal    
DOI: 10.1007/s12152-012-9153-9     Document Type: Article

References (28)

1. Sahakian, B.J., and S. Morein-Zamir. 2011. Neuroethical issues in cognitive enhancement. Journal of Psychopharmacology 25(2): 197-204.
2. Pieters, T., and S. Snelders. 2009. Psychotropic drug use: between healing and enhancing the mind. Neuroethics 2(2): 63-73.
3. Bostrom, N., and A. Sandberg. 2009. Cognitive enhancement: methods, ethics, regulatory challenges. Science and Engineering Ethics 15(3): 311-341.
4. Schermer, M. 2008. On the argument that enhancement is «cheating». Journal of Medical Ethics 34(2): 85-88.
5. McCabe, S.E., J.R. Knight, C.J. Teter, and H. Wechsler. 2005. Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey. Addiction 100(1): 96-106.
6. Franke, A.G., C. Bonertz, M. Christmann, M. Huss, A. Fellgiebel, E. Hildt, and K. Lieb. 2011. Non-medical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students in Germany. Pharmacopsychiatry 44(2): 60-66.
7. Lucke, J.C., S. Bell, B. Partridge, and W.D. Hall. 2011. Deflating the Neuroenhancement Bubble. AJOB Neuroscience 2(4): 38-43.
8. Chatterjee, A. 2009. Is it acceptable for people to take methylphenidate to enhance performance? British Medical Journal 338: 1532-1533.
9. Forlini, C., and E. Racine. 2009. Autonomy and coercion in academic «cognitive enhancement» using methylphenidate: perspectives of key stakeholders. Neuroethics 2(3): 163-177.
10. Forlini, C., and E. Racine. 2010. Stakeholder perspectives and reactions to "academic" cognitive enhancement: unsuspected meaning of ambivalence and analogies. Public Understanding of Science. doi: 10.1177/0963662510385062.
11. Appel, J.M. 2008. When the boss turns pusher: a proposal for employee protections in the age of cosmetic neurology. Joural of Medical Ethics 34(8): 616-618.
12. Schoomaker, E.B. 2007. Military medical research on cognitive performance: the warfighter's competitive edge. Aviation, Space, and Environmental Medicine. Special Issue: Operational applications of cognitive performance enhancement technologies 78(5, Sect II, Suppl): B4-B6.
13. Warren, O.J., D.R. Leff, T. Athanasiou, C. Kennard, and A. Darzi. 2009. The neurocognitive enhancement of surgeons: an ethical perspective. Journal of Surgical Research 152(1): 167-172.
14. Dees, R.H. 2007. Better brains, better selves? The ethics of neuroenhancements. Kennedy Institute of Ethics Journal 17(4): 371-395.
15. DeSantis, A., S.M. Noar, and E.M. Webb. 2010. Speeding through the frat house: a qualitative exploration of nonmedical ADHD stimulant use in fraternities. Journal of Drug Education 40(2): 157-171.
16. DeSantis, A.D., and A.C. Hane. 2010. «Adderall is definitely not a drug»: justifications for the illegal use of ADHD stimulants. Substance Use & Misuse 45(1-2): 31-46.
17. DeSantis, A., E.M. Webb, and S.M. Noar. 2008. Illicit use of prescription ADHD medications on a college campus: a multimethodological approach. Journal of American College Health 57(3): 315-324.
18. Cakic, V. 2009. Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology. Journal of Medical Ethics 35(10): 611-615.
19. Greely, H., B. Sahakian, J. Harris, R.C. Kessler, M. Gazzaniga, P. Campbell, and M.J. Farah. 2008. Towards responsible use of cognitive-enhancing drugs by the healthy. Nature 456(7223): 702-705.
20. Singh, I., and K.J. Kelleher. 2010. Neuroenhancement in young people: proposal for research, policy, and clinical management. AJOB Neuroscience 1(1): 3-16.
21. DeSantis, A., S.M. Noar, and E.M. Webb. 2009. Nonmedical ADHD stimulant use in fraternities. Journal of Studies on Alcohol and Drugs 70(6): 952-954.
22. Hansen, E.C. 2006. Successful qualitative health research. Crows Nest, NSW: Allen & Unwin.
23. Hill, C.E., S. Knox, B.J. Thompson, E.N. Williams, S.A. Hess, and N. Ladany. 2005. Consensual qualitative research: an update. Journal of Counseling Psychology 52(2): 196-205.
24. Hill, C.E., B.J. Thompson, and E.N. Williams. 1997. A guide to conducting consensual qualitative research. The Counseling Psychologist 25(4): 517-572.
25. Fox, N.J., and K.J. Ward. 2008. Pharma in the bedroom. and the kitchen. the pharmaceuticalisation of daily life. Sociology of Health & Illness 30(6): 856-868.
26. Hall, W. 2004. Feeling 'better than well:' can our experiences with psychoactive drugs help us to meet the challenges of novel neuroenhancement methods? EMBO Reports 5(12): 1105-1109.
27. Farah, M.J. 2002. Emerging ethical issues in neuroscience. Nature Neuroscience 5(11): 1123-1129.
28. Forlini, C., and E. Racine. 2009. Disagreements with implications: diverging discourses on the ethics of non-medical use of methylphenidate for performance enhancement. BMC Medical Ethics 10: 9. doi: 10.1186/1472-6939-10-9.